Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria-Reference-Cited by-同舟云学术

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria

Published:2007-12-20 Issue:3 Volume:22 Page:487-495
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Matutes E,Oscier D,Montalban C,Berger F,Callet-Bauchu E,Dogan A,Felman P,Franco V,Iannitto E,Mollejo M,Papadaki T,Remstein E D,Salar A,Solé F,Stamatopoulos K,Thieblemont C,Traverse-Glehen A,Wotherspoon A,Coiffier B,Piris M A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2405068.pdf

Reference81 articles.

1. Schmid C, Kirkham N, Diss T, Isaacson PG . Splenic marginal zone cell lymphoma. Am J Surg Pathol 1992; 16: 455–466.

2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392.

3. Catovsky D, Matutes E . Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Semin Hematol 1999; 36: 148–154.

4. Arcaini L, Orlandi E, Scotti M, Brusamolino E, Passamonti F, Burcheri S et al. Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma. Clin Lymphoma 2004; 4: 250–252.

5. Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case–control study. Blood 2003; 102: 996–999.

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tell-tale immune-related neurological syndromes: Should we look for and underlying low-grade B-cell lymphoma? A retrospective study on 12 cases;Pathology - Research and Practice;2024-08

2. The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications;Exploration of Targeted Anti-tumor Therapy;2024-07-23

3. Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance;Internal Medicine Journal;2024-06

4. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study;Haematologica;2024-03-14

5. Splenic marginal zone lymphoma with monoclonal IgG: A case report;Medicine;2024-02-09